Literature DB >> 20722210

Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy.

G Cherian, I F Brockington, P M Shah, C M Oakley, J F Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 20722210      PMCID： PMC1844376          DOI： 10.1136/bmj.1.5492.895

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Hemogynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs.

Authors:  E BRAUNWALD; P A EBERT
Journal:  Am J Cardiol       Date:  1962-10       Impact factor: 2.778

2.  EFFECTS OF RESPIRATION ON THE HEMODYNAMICS OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  P M SHAH; T YIPINTSOI; R AMARASINGHAM; C M OAKLEY
Journal:  Am J Cardiol       Date:  1965-06       Impact factor: 2.778

3.  SURGICAL TREATMENT AND POST-OPERATIVE HAEMODYNAMIC STUDIES IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  H H BENTALL; W P CLELAND; C M OAKLEY; P M SHAH; R E STEINER; J F GOODWIN
Journal:  Br Heart J       Date:  1965-07

4.  Obstructive cardiomyopathy simulating aortic stenosis.

Authors:  J F GOODWIN; A HOLLMAN; W P CLELAND; D TEARE
Journal:  Br Heart J       Date:  1960-06

5.  Pressure gradients without obstruction. A new concept of "hypertrophic subaortic stenosis".

Authors:  J M Criley; K B Lewis; R I White; R S Ross
Journal:  Circulation       Date:  1965-12       Impact factor: 29.690

6.  Can outflow obstruction be induced within the normal left ventricle?

Authors:  A G Marrow; J S Vasko; R P Henney; R K Brawley
Journal:  Am J Cardiol       Date:  1965-10       Impact factor: 2.778
  6 in total
  18 in total

Review 1.  Nonobstructive and obstructive hypertrophic cardiomyopathies.

Authors:  J Ross; R Shabetai; G Curtis; R L Engler; D L Costello; M M LeWinter; A D Johnson; C B Higgins; G Gregoratos; J R Utley; R Shabetai
Journal:  West J Med       Date:  1979-04

2.  Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.

Authors:  P J Hubner; G M Ziady; G K Lane; T Hardarson; B Scales; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1973-11

Review 3.  [Adrenergic alpha and beta receptors and their specific inhibitors].

Authors:  E Muscholl; K H Rahn
Journal:  Klin Wochenschr       Date:  1968-02-01

4.  Editorial: Hypertrophic cardiomyopathy.

Authors: 
Journal:  Br Med J       Date:  1974-05-11

5.  Propanalol in Fallot's tetralogy.

Authors:  C C Varkey
Journal:  Indian J Pediatr       Date:  1973-08       Impact factor: 1.967

6.  Long-term treatment with propranolol in selected cases of Fallot's tetralogy.

Authors:  B O Eriksson; C Thorén; P Zetterqvist
Journal:  Br Heart J       Date:  1969-01

7.  Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis.

Authors:  H J Matlof; D C Harrison
Journal:  Br Heart J       Date:  1973-02

8.  Panel discussion: the treatment of hypertrophic cardiomyopathy with beta-adrenergic blockade.

Authors: 
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

Review 9.  Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.

Authors:  C D Furberg
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  The Brockenbrough-Braunwald-Morrow sign.

Authors:  Alejandro R Trevino; John Buergler
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.